CSF/plasma levels, transthyretin stabilisation and safety of multiple doses of tolcapone in subjects with hereditary ATTR amyloidosis-Reference-Cited by-同舟云学术

CSF/plasma levels, transthyretin stabilisation and safety of multiple doses of tolcapone in subjects with hereditary ATTR amyloidosis

Author:

Takahashi Yusuke¹,Ohashi Nobuhiko¹,Takasone Ken¹,Yoshinaga Tsuneaki¹,Yazaki Masahide²³,Roberts Michael⁴,Glidden Paul F.⁴,Sekijima Yoshiki¹²

Affiliation:

1. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan

2. Department of Biomedical Laboratory Sciences, Shinshu University School of Health Sciences, Matsumoto, Japan

3. Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan

4. Corino Therapeutics, Inc, New York, NY, USA

Funder

The study was supported by Corino Therapeutics, Inc

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

Reference31 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Amyloid Polyneuropathy and Treatment;Current Treatment Options in Neurology;2024-02-01